These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4006778)

  • 1. The clinical use of oral flecainide.
    Slama R; LeClercq JF
    Drugs; 1985; 29 Suppl 4():28-9. PubMed ID: 4006778
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of tocainide, encainide, lorcainide and flecainide for supraventricular arrhythmias.
    Orning OM
    Eur Heart J; 1984 Sep; 5 Suppl B():81-6. PubMed ID: 6437821
    [No Abstract]   [Full Text] [Related]  

  • 3. Long term use of flecainide in patients with supraventricular tachycardia.
    Neuss H
    Drugs; 1985; 29 Suppl 4():21-5. PubMed ID: 4006776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of flecainide in supraventricular arrhythmias].
    Chouty F; Leclercq JF; Coumel P
    Ann Cardiol Angeiol (Paris); 1986 Apr; 35(4):237-41. PubMed ID: 3740779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of flecainide acetate for refractory junctional tachycardias in children with the Wolff-Parkinson-White syndrome.
    Ward DE; Jones S; Shinebourne EA
    Am J Cardiol; 1986 Apr; 57(10):787-90. PubMed ID: 3962866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical usefulness of flecainide acetate in the treatment of paroxysmal supraventricular arrhythmias.
    Camm AJ; Hellestrand KJ; Nathan AW; Bexton RS
    Drugs; 1985; 29 Suppl 4():7-13. PubMed ID: 4006783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The limitations of anti-arrhythmic drug therapy.
    Shimomura K; Ohe T
    Jpn Circ J; 1983 Jan; 47(1):153-7. PubMed ID: 6827772
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of oral and injectable flecainide in patients with an accessory atrioventricular pathway].
    Fauchier JP; Cosnay P; Rouesnel P; Moquet B; Bonnet P; Scala PJ; Demeyer JF
    Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():81-90. PubMed ID: 3938264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of cardiac arrhythmias with N-propyl-ajmalinium-hydrogentartrat (Neo-Gilurytmal (author's transl)].
    So CS; Oversohl K; Seidl KF
    Med Klin; 1974 May; 69(18):814-7. PubMed ID: 4134646
    [No Abstract]   [Full Text] [Related]  

  • 10. Loss of efficacy of flecainide in the Wolff-Parkinson-White syndrome after isoproterenol administration.
    Brembilla-Perrot B; Admant P; Le Helloco A; Pernot C
    Eur Heart J; 1985 Dec; 6(12):1074-8. PubMed ID: 3830711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Oral treatment of arrhythmias in the WPW and LGL-syndrome using Amidonal].
    Brisse B; Bender F
    Med Monatsschr; 1977 Sep; 31(9):412-4. PubMed ID: 904574
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of ajmaline in the therapy of various heart arrhythmias and comparison with the classic antiarrhythmic drug quinidine].
    Scardino R; Colao G; Didonato F; Sepe V
    Minerva Med; 1970 Sep; 61(78):4289-300. PubMed ID: 4930956
    [No Abstract]   [Full Text] [Related]  

  • 13. Conversion of supraventricular arrhythmias to sinus rhythm using flecainide.
    Goy JJ; Grbic M; Hurni M; Finci L; Maendly R; Duc J; Sigwart U
    Eur Heart J; 1985 Jun; 6(6):518-24. PubMed ID: 4043101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Unfavorable course of the ventricular preexcitation syndrome. Apropos of 3 cases].
    Poveda Sierra J; Pajarón A; Medrano GA
    Arch Inst Cardiol Mex; 1973; 43(6):837-47. PubMed ID: 4773501
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral flecainide for suppression of ventricular arrhythmias.
    Vanhaleweyk G; Balakumaran K; Lubsen J; Roelandt J; Hugenholtz PG
    Cardiology; 1984; 71(1):30-9. PubMed ID: 6722846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tachyarrhythmias in Wolff-Parkinson-White syndrome. Antiarrhythmic drug therapy.
    Chung EK
    JAMA; 1977 Jan; 237(4):376-9. PubMed ID: 576173
    [No Abstract]   [Full Text] [Related]  

  • 17. [Arrhythmias in Wolff-Parkinson-White syndrome].
    Dabrowski A
    Kardiol Pol; 1976; 19(5):395-401. PubMed ID: 994367
    [No Abstract]   [Full Text] [Related]  

  • 18. Flecainide: a new antiarrhythmic drug.
    Med Lett Drugs Ther; 1986 Feb; 28(707):19-20. PubMed ID: 3951388
    [No Abstract]   [Full Text] [Related]  

  • 19. A study of the use of flecainide acetate in the long-term management of cardiac arrhythmias.
    Wiseman MN; Elstob JE; Camm AJ; Nathan AW
    Pacing Clin Electrophysiol; 1990 Jun; 13(6):767-75. PubMed ID: 1695357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic therapy with flecainide for asymptomatic Wolff-Parkinson-White syndrome in an infant with severe left ventricular dyssynchrony.
    Suzuki S; Hokosaki T; Iwamoto M
    Cardiol Young; 2018 Jul; 28(7):970-973. PubMed ID: 29848398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.